Literature DB >> 7833703

Clinical gastroenterology.

I Forgacs1.   

Abstract

Mesh：

Year:  1995        PMID： 7833703      PMCID： PMC2548508          DOI： 10.1136/bmj.310.6972.113

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  41 in total

1.  The treatment of idiopathic hyperhidrosis by glycopyrronium bromide and tap water iontophoresis.

Authors:  E Abell; K Morgan
Journal:  Br J Dermatol       Date:  1974-07       Impact factor: 9.302

Review 2.  Cancer surveillance in ulcerative colitis--a time for reappraisal.

Authors:  A T Axon
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

3.  New approaches to treating oesophageal cancer.

Authors:  S O'Reilly; A Forastiere
Journal:  BMJ       Date:  1994-05-14

4.  Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial Investigators.

Authors:  B G Feagan; J W McDonald; J Rochon; A Laupacis; R N Fedorak; D Kinnear; F Saibil; A Groll; A Archambault; R Gillies
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

5.  Cyclosporine in severe ulcerative colitis refractory to steroid therapy.

Authors:  S Lichtiger; D H Present; A Kornbluth; I Gelernt; J Bauer; G Galler; F Michelassi; S Hanauer
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

6.  The surgical treatment of upper limb hyperhidrosis.

Authors:  P S Malone; A E Cameron; J A Rennie
Journal:  Br J Dermatol       Date:  1986-07       Impact factor: 9.302

7.  Allelic loss of chromosome 18q and prognosis in colorectal cancer.

Authors:  J Jen; H Kim; S Piantadosi; Z F Liu; R C Levitt; P Sistonen; K W Kinzler; B Vogelstein; S R Hamilton
Journal:  N Engl J Med       Date:  1994-07-28       Impact factor: 91.245

8.  Bran and irritable bowel syndrome: time for reappraisal.

Authors:  C Y Francis; P J Whorwell
Journal:  Lancet       Date:  1994-07-02       Impact factor: 79.321

9.  A comparison of budesonide with prednisolone for active Crohn's disease.

Authors:  P Rutgeerts; R Löfberg; H Malchow; C Lamers; G Olaison; D Jewell; A Danielsson; H Goebell; O O Thomsen; H Lorenz-Meyer
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

10.  Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group.

Authors:  G R Greenberg; B G Feagan; F Martin; L R Sutherland; A B Thomson; C N Williams; L G Nilsson; T Persson
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.